Valuation: Baxter International Inc.

Capitalization 910.13Cr 784.72Cr 708.37Cr 679.7Cr 1.24TCr 84TCr 1.3TCr 8.37TCr 3.35TCr 40TCr 3.42TCr 3.34TCr 1,43500Cr P/E ratio 2026 *
29.3x
P/E ratio 2027 * 19.9x
Enterprise value 1.56TCr 1.34TCr 1.21TCr 1.16TCr 2.12TCr 1,43300Cr 2.22TCr 14TCr 5.75TCr 69TCr 5.85TCr 5.73TCr 2,45700Cr EV / Sales 2026 *
1.37x
EV / Sales 2027 * 1.29x
Free-Float
74.36%
Yield 2026 *
0.22%
Yield 2027 * 0.24%
1 day-4.89%
1 week-13.16%
Current month-13.16%
1 month-18.59%
3 months-4.58%
6 months-27.56%
Current year-7.43%
1 week 17.54
Extreme 17.535
19.97
1 month 17.54
Extreme 17.535
22.41
Current year 17.54
Extreme 17.535
22.41
1 year 17.4
Extreme 17.4
37.74
3 years 17.4
Extreme 17.4
50.21
5 years 17.4
Extreme 17.4
89.7
10 years 17.4
Extreme 17.4
95.19
Manager TitleAgeSince
Chief Executive Officer 49 01/08/2025
Director of Finance/CFO 56 18/10/2023
Chief Tech/Sci/R&D Officer - 01/01/2021
Director TitleAgeSince
Director/Board Member 75 06/02/2017
Director/Board Member 66 18/02/2019
Director/Board Member 65 01/01/2019
Change 5d. change 1-year change 3-years change Capi.($)
-4.89%-13.16%-50.08%-55.45% 956.95Cr
-1.33%-5.84%-18.89%+6.63% 19TCr
-2.27%-6.92%-2.39%+10.95% 12TCr
-0.23%-3.68%+41.25%+129.11% 6.99TCr
+1.31%+0.87%+61.53%+102.20% 6.01TCr
-1.66%-5.30%-25.84%-29.25% 4.84TCr
-0.50%-7.75% - - 3.58TCr
-3.66%-7.26%-14.35%-39.87% 2.72TCr
-3.35%-8.65%-0.75%+23.82% 2.34TCr
-3.26%-10.10%-16.47%-47.31% 1.91TCr
Average -1.98%-7.00%-2.89%+11.20% 6.06TCr
Weighted average by Cap. -1.40%-5.99%+0.34%+25.21%

Financials

2026 *2027 *
Net sales 1.14TCr 978.86Cr 883.63Cr 847.86Cr 1.55TCr 1,04300Cr 1.62TCr 10TCr 4.18TCr 50TCr 4.26TCr 4.17TCr 1,78900Cr 1.16TCr 999.97Cr 902.69Cr 866.14Cr 1.58TCr 1,06600Cr 1.65TCr 11TCr 4.28TCr 51TCr 4.35TCr 4.26TCr 1,82800Cr
Net income 36Cr 31Cr 28Cr 27Cr 49Cr 3.31TCr 51Cr 331.23Cr 132.7Cr 1.59TCr 135.11Cr 132.23Cr 5.67TCr 48Cr 42Cr 38Cr 36Cr 66Cr 4.44TCr 69Cr 444.04Cr 177.89Cr 2.13TCr 181.12Cr 177.26Cr 7.61TCr
Net Debt 648.65Cr 559.26Cr 504.86Cr 484.42Cr 883.34Cr 60TCr 924.45Cr 5.97TCr 2.39TCr 29TCr 2.43TCr 2.38TCr 1,02200Cr 580.84Cr 500.8Cr 452.08Cr 433.78Cr 790.99Cr 53TCr 827.81Cr 5.34TCr 2.14TCr 26TCr 2.18TCr 2.13TCr 92TCr
Logo Baxter International Inc.
Baxter International Inc. specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows: - systems for delivering medications and intravenous therapy (47.1%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, and biosurgery (fibrin sealant, surgical gel, hemostatic pads, etc.), etc.; - medical equipment (27.3%): smart bed systems, patient monitoring systems, diagnostic equipment, respiratory health devices, and advanced operating room equipment, etc.; - pharmaceutical products and services (22.2%): injectable medications, inhaled anesthetics, and drug compounding services; - other (3.4 %). The United States account for 54.4% of net sales.
Employees
37,500
Date Price Change Volume
06/26/06 17.69 $ -4.89% 1,07,08,769
05/26/05 18.60 $ -2.26% 1,08,56,292
04/26/04 19.03 $ 0.00% 86,53,038
03/26/03 19.03 $ -3.35% 90,39,603
02/26/02 19.69 $ -3.34% 72,87,906
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
17
Last Close Price
17.69USD
Average target price
21.63USD
Spread / Average Target
+22.29%

Quarterly revenue - Rate of surprise